Published in Acta Neurochir (Wien) on September 08, 2015
Seizure outcomes of temporal lobe epilepsy surgery in patients with normal MRI and without specific histopathology. Acta Neurochir (Wien) (2017) 0.75
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Automatically parcellating the human cerebral cortex. Cereb Cortex (2004) 18.32
A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med (2001) 13.85
Accurate and robust brain image alignment using boundary-based registration. Neuroimage (2009) 6.27
Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA (2012) 5.40
Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology (1998) 4.41
Highly accurate inverse consistent registration: a robust approach. Neuroimage (2010) 3.98
Epilepsy surgery for pharmacoresistant temporal lobe epilepsy: a decision analysis. JAMA (2008) 3.01
Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain (2004) 2.08
Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol (2005) 1.99
The use of SPECT and PET in routine clinical practice in epilepsy. Curr Opin Neurol (2007) 1.41
Epilepsy surgery outcomes in temporal lobe epilepsy with a normal MRI. Epilepsia (2009) 1.41
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage (2003) 1.33
Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain (2003) 1.22
Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy. Neurology (1999) 1.20
Is epileptogenic cortex truly hypometabolic on interictal positron emission tomography? Ann Neurol (2000) 1.12
Benzodiazepine receptor increases after repeated seizures: evidence for localization to dentate granule cells. Proc Natl Acad Sci U S A (1982) 1.11
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med (2003) 1.08
Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review. Epilepsia (2008) 1.06
Objective detection of epileptic foci by 18F-FDG PET in children undergoing epilepsy surgery. J Nucl Med (2010) 1.05
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology (2001) 1.04
Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol (2006) 1.03
Antiepileptic drugs and cerebral glucose metabolism. Epilepsia (1988) 1.03
The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain (2006) 1.02
Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. Brain (2005) 1.01
Topography of interictal glucose hypometabolism in unilateral mesiotemporal epilepsy. Neurology (1996) 1.00
[18F]FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage. Arch Neurol (2001) 1.00
Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain (1998) 0.98
The topography and significance of extratemporal hypometabolism in refractory mesial temporal lobe epilepsy examined by FDG-PET. Epilepsia (2010) 0.93
In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology (2001) 0.92
[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology (2000) 0.92
The added value of [18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia (2007) 0.91
Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain (2002) 0.91
Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry (1993) 0.91
In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology (1993) 0.90
11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology (2000) 0.90
Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain (2005) 0.90
Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Childs Nerv Syst (2006) 0.89
Postoperative changes in cerebral metabolism in temporal lobe epilepsy. Arch Neurol (2000) 0.87
11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology (1997) 0.85
FDG-PET images quantified by probabilistic atlas of brain and surgical prognosis of temporal lobe epilepsy. Epilepsia (2002) 0.85
Long-term seizure and social outcomes following temporal lobe surgery for intractable epilepsy during childhood. Epilepsy Res (2008) 0.84
Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy. Epilepsia (2003) 0.84
Fluorodeoxyglucose-positron emission tomographic imaging for the diagnosis of mesial temporal lobe epilepsy. Neurosurgery (2008) 0.84
Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia (1996) 0.81
MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage (1996) 0.81
Seizure outcome 1 year after temporal lobe epilepsy: an analysis of MR volumetric and clinical parameters. Acta Neurochir (Wien) (2012) 0.81
Regional increases in [11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand (1998) 0.80
PET: central benzodiazepine neuroreceptor mapping in localization-related epilepsies. Adv Neurol (2000) 0.80
Hypometabolism and interictal spikes during positron emission tomography scanning in temporal lobe epilepsy. Eur Neurol (2002) 0.80
The role of radionuclide imaging in epilepsy, Part 1: Sporadic temporal and extratemporal lobe epilepsy. J Nucl Med (2013) 0.78
Randomized controlled trial of 2.5-cm versus 3.5-cm mesial temporal resection in temporal lobe epilepsy--Part 1: intent-to-treat analysis. Acta Neurochir (Wien) (2010) 0.77
Tailored temporal lobectomy for medically intractable epilepsy: evaluation of pathology and predictors of outcome. Neurosurgery (2012) 0.77
Preoperative and postoperative glucose consumption in mesiobasal and lateral temporal lobe epilepsy. Neurology (1994) 0.76
Seizure outcomes of temporal lobe epilepsy surgery in patients with normal MRI and without specific histopathology. Acta Neurochir (Wien) (2017) 0.75